Gentamicin-loaded bone cement with clindamycin or fusidic acid added: Biofilm formation and antibiotic release

✍ Scribed by Daniëlle Neut; Erik P. de Groot; Rick S. Z. Kowalski; Jim R. van Horn; Henny C. van der Mei; Henk J. Busscher

• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 78 KB
• Volume: 73A
• Category: Article
• ISSN: 1549-3296
• DOI: 10.1002/jbm.a.30253

✦ Synopsis

Abstract

The formation of staphylococcal biofilms on experimental bone cements, loaded with 0.5 or 1.0 g of active gentamicin and an additional equivalent amount of gentamicin, clindamycin, or fusidic acid was investigated. The biofilms were formed in a modified Robbins device over a 3‐day time span and the influence of the additional antibiotics was quantified by expressing the number of colony forming units relative to the corresponding bone cement containing only gentamicin. Combinations of gentamicin with either fusidic acid or clindamycin reduced growth of clinical isolates of both gentamicin‐sensitive Staphylococcus aureus and gentamicin‐resistant coagulase‐negative staphylococci to approximately 28%. To determine whether adding a second antibiotic has influence on the gentamicin release, cement blocks were placed in phosphate buffer and aliquots were taken at designated sampling intervals. The influence of the additional antibiotics was quantified by expressing the percentage released of the total amount of antibiotic incorporated in the different bone cements. After 3 days, all bone cements had released similar percentages of gentamicin, whereas more clindamycin and fusidic acid were released after doubling their concentration in the bone cements. In conclusion, bone cements loaded with combinations of gentamicin and clindamycin or fusidic acid are more effective in preventing biofilm formation than bone cements with gentamicin as a single drug. In addition, the presence of clindamycin or fusidic acid in gentamicin‐loaded bone cement has no influence on the total gentamicin release. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res 73A: 165–170, 2005